Business Context and Reporting Period
Company: Evolv Technologies Holdings, Inc. (EVLV)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Business Overview: Evolv is a security technology company providing AI-powered screening solutions (Evolv Express and Evolv eXpedite) via a Security-as-a-Service model. The company serves education, healthcare, sports, and entertainment sectors. As of June 30, 2026, the company is no longer a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2026 |
Six Months Ended June 30, 2026 |
|---|---|---|
| Total Revenue | $43,753 | $90,081 |
| Gross Profit | $21,952 | $45,551 |
| Gross Margin | 50.2% | 50.6% |
| Net Loss | $(9,298) | $(14,307) |
| Adjusted EBITDA | $4,431 | $8,375 |
| Cash from Operating Activities | N/A | $8,723 |
| Cash and Cash Equivalents | $52,696 | $52,696 |
| Marketable Securities | $9,936 | $9,936 |
| Total Debt (Outstanding) | $30,000 | $30,000 |
| Available Borrowing Capacity | $45,000 | $45,000 |
Note: Cash from Operating Activities for the three-month period is not explicitly provided in the summary tables, but the six-month figure is positive.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 34% year-over-year (Q2 2026 vs. Q2 2025) and 40% for the six-month period. This was driven by a 260% increase in product revenue and a 23% increase in subscription revenue.
- Profitability Improvement: Net loss narrowed significantly from $40.5 million in Q2 2025 to $9.3 million in Q2 2026. Adjusted EBITDA improved from $2.1 million to $4.4 million for the quarter.
- Expense Reduction: General and Administrative (G&A) expenses decreased 19% year-over-year in Q2, primarily due to a $4.7 million reduction in non-recurring legal and consulting fees related to prior investigations and restatements.
- Debt Financing: The company entered a $75 million credit facility in July 2025. As of June 30, 2026, $30 million of the initial term loan was drawn, resulting in interest expense of $1.0 million for the quarter (compared to zero in the prior year).
- License Revenue Decline: License fee revenue dropped 71% year-over-year due to the expiration of the Distribution and License Agreement with Columbia Tech on December 31, 2025. This revenue stream has been replaced by direct product sales.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue generating net losses for the foreseeable future while investing in growth. The company projects that current cash, marketable securities ($62.6 million total), and available debt capacity ($45 million) are sufficient to fund operations for at least 12 months.
- Covenants: The company is in full compliance with its credit agreement covenants, including a minimum Annual Recurring Revenue (ARR) of $108.7 million as of June 30, 2026. A minimum EBITDA covenant will take effect on June 30, 2027.
- Key Risks:
- Internal Controls: The company disclosed material weaknesses in internal control over financial reporting, which contributed to prior restatements. Remediation is ongoing but not yet complete.
- Legal Proceedings: A securities class action lawsuit was settled in principle for $15.0 million (with $14.3 million expected insurance recovery). Derivative lawsuits were also settled in principle. An SEC investigation into marketing practices is ongoing.
- Supply Chain: The company is transitioning manufacturing to a new partner (Plexus Corp.) to diversify supply, which carries onboarding risks.
- Market Volatility: The company faces risks related to the adoption of AI-based security screening and potential changes in the regulatory environment regarding AI and data privacy.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of the remediation plan for material weaknesses in internal controls, specifically regarding the period-end reporting process and IT general controls.
- Legal Settlement Finalization: Confirm the final court approval and funding of the $15.0 million class action settlement and the $1.3 million derivative lawsuit settlement.
- Debt Covenant Compliance: Monitor future ARR and EBITDA performance to ensure continued compliance with the MidCap Credit Agreement, particularly the EBITDA covenant effective June 2027.
- Supply Chain Transition: Assess the impact of the new contract manufacturing agreement with Plexus Corp. on production capacity, quality, and cost of revenue.
- Revenue Mix Shift: Analyze the sustainability of the shift from license fees to direct product sales and the associated impact on gross margins and working capital.